Skip to main content
. 2022 Jul 25;12:876981. doi: 10.3389/fonc.2022.876981

Figure 3.

Figure 3

The signature retained great prognostic value in different subgroups of AML patients. Survival analysis in the two risk groups under diverse situations classified by several clinical features including age (A, B), gender (C, D), status of chromosome (E, F), status of NPM1 (G, H), status of FLT3 (I, J), status of RAS (K, L) and status of IDH1 (M, N).